Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP605922.RArgU_I5A1T2cxjn-tDCTDr7XjxnWbb8kZzkefqK9Z0s0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP605922.RArgU_I5A1T2cxjn-tDCTDr7XjxnWbb8kZzkefqK9Z0s0130_assertion type Assertion NP605922.RArgU_I5A1T2cxjn-tDCTDr7XjxnWbb8kZzkefqK9Z0s0130_head.
- NP605922.RArgU_I5A1T2cxjn-tDCTDr7XjxnWbb8kZzkefqK9Z0s0130_assertion description "[Four hundred sixty-seven patients who were diagnosed as having de novo MDS at the Division of Hematology, University of Pavia (Pavia, Italy), between 1992 and 2002, were evaluated retrospectively for clinical and hematologic features at diagnosis, overall survival (OS), and progression to leukemia (leukemia-free survival).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605922.RArgU_I5A1T2cxjn-tDCTDr7XjxnWbb8kZzkefqK9Z0s0130_provenance.
- NP605922.RArgU_I5A1T2cxjn-tDCTDr7XjxnWbb8kZzkefqK9Z0s0130_assertion evidence source_evidence_literature NP605922.RArgU_I5A1T2cxjn-tDCTDr7XjxnWbb8kZzkefqK9Z0s0130_provenance.
- NP605922.RArgU_I5A1T2cxjn-tDCTDr7XjxnWbb8kZzkefqK9Z0s0130_assertion SIO_000772 16186598 NP605922.RArgU_I5A1T2cxjn-tDCTDr7XjxnWbb8kZzkefqK9Z0s0130_provenance.
- NP605922.RArgU_I5A1T2cxjn-tDCTDr7XjxnWbb8kZzkefqK9Z0s0130_assertion wasDerivedFrom befree-20150227 NP605922.RArgU_I5A1T2cxjn-tDCTDr7XjxnWbb8kZzkefqK9Z0s0130_provenance.
- NP605922.RArgU_I5A1T2cxjn-tDCTDr7XjxnWbb8kZzkefqK9Z0s0130_assertion wasGeneratedBy ECO_0000203 NP605922.RArgU_I5A1T2cxjn-tDCTDr7XjxnWbb8kZzkefqK9Z0s0130_provenance.